Sol Gel Technologies Ltd (SLGL)

Sol Gel Technologies Ltd (SLGL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $227M; returns 1 day +3.1%, 1 week +8.1%, 1 year +74.1%.

Sol-Gel Technologies Ltd. (NASDAQ: SLGL) is an Israel-based clinical-stage dermatology company primarily focused on developing and commercializing innovative topical drug products for the treatment of various skin diseases. The company leverages its proprietary microencapsulation technology platform to enhance the tolerability and stability of active pharmaceutical ingredients.

Groups SLGL belongs to

• Biotechnology
• Israel Companies
• Dermatology
• Israel
• Biopharmaceutical
• Clinical Stage Biotech
• Pharmaceuticals
• Clinical Stage
• Rare Diseases
• Healthcare
• Oncology
• Commercial Stage Biotech

SLGL financial model: income statement, cash flow and balance sheet